Rare diseases
Investigational molecules
Locations
Back to Romania322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
RomaniaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
RomaniaLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
RomaniaStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
RomaniaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
RomaniaStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
RomaniaStudy on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence
RomaniaStudy Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
RomaniaStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
RomaniaStudy of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy
RomaniaStudy of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
RomaniaStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.
Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.
Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.
Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.
Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.
Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.
Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.
Studies evaluate both targeted therapies and broader immunological approaches.
Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.
Trials explore novel treatment approaches for complex neurological and psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
